Stem Cell Research (Apr 2022)

CRISPR/Cas9-engineered human ES cells harboring heterozygous and homozygous c-KIT knockout

  • Marcelo A.S. de Toledo,
  • Xuhuang Fu,
  • Frederick Kluge,
  • Katrin Götz,
  • Susanne Schmitz,
  • Paul Wanek,
  • Herdit M. Schüler,
  • Kristina Pannen,
  • Nicolas Chatain,
  • Steffen Koschmieder,
  • Tim H. Brümmendorf,
  • Martin Zenke

Journal volume & issue
Vol. 60
p. 102732

Abstract

Read online

The receptor tyrosine kinase c-KIT (CD117) has a key role in hematopoiesis and is a marker for endothelial and cardiac progenitor cells. In vivo, deficiency of c-KIT is lethal and therefore using CRISPR/Cas9 editing we generated heterozygous and homozygous c-KIT knockout human embryonic stem cell (ES cell) lines. The c-KIT knockout left ES cell pluripotency unaffected as shown by immunofluorescence and trilineage differentiation potential. Heterozygous and homozygous c-KIT knockouts showed complete loss of exon 17, resulting in ablation of c-KIT protein from the cell surface. c-KIT knockout ES cells provide a valuable tool for further investigating c-KIT biology.

Keywords